Q2 2025 saw a slight decline in subscribers and net sales due to softer D2C market conditions, but partnership revenue grew over 60% year-over-year and now represents nearly 10% of total revenue. Profitability remains strong, and the company is advancing its sleep apnea screening project.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.